European public procurement and grants data from official registers · Data as of 18 November 2026; updated daily.

Market report

Nervous system drug tenders in Italy — market report, January 2025

Nervous system drug tenders in Italy in January 2025: 63 tenders published (+125% month on month), estimated at €2,231,759 in total, and 26 contracts awarded (+53% month on month), worth €399,596 (awarded value). Buyers with the most tenders: Sanitaetsbetrieb der Autonomen Provinz Bozen (12), Azienda Sanitaria Provinciale (8) and Azienda Sanitaria Locale TO3 (7); most contracts won: Aurobindo Pharma (Italia) S.R.L. in Forma Abbreviata Aurobindo S.R.L. (2), Alloga (Italia) S.R.L. (2) and OTTOPHARMA S.R.L. (2). On average 1.0 bids per contract; 100% of contracts had a single bid. Report made on 27 October 2026.

Tenders published
63
Contracts awarded
26
Contract value awarded
€399,596
Bids per contract
1.0
Tenders published per month
020406080Feb 24: —Feb 24Mar 24: 23Mar 24: 23Mar 24Apr 24: 19Apr 24: 19Apr 24May 24: 23May 24: 23May 24Jun 24: 27Jun 24: 27Jun 24Jul 24: 38Jul 24: 38Jul 24Aug 24: 15Aug 24: 15Aug 24Sep 24: 35Sep 24: 35Sep 24Oct 24: 50Oct 24: 50Oct 24Nov 24: 26Nov 24: 26Nov 24Dec 24: 28Dec 24: 28Dec 24Jan 25: 63Jan 25: 6363Jan 25
Contracts awarded per month
0102030Feb 24: —Feb 24Mar 24: 14Mar 24: 14Mar 24Apr 24: 12Apr 24: 12Apr 24May 24: 14May 24: 14May 24Jun 24: 3Jun 24: 3Jun 24Jul 24: 17Jul 24: 17Jul 24Aug 24: 8Aug 24: 8Aug 24Sep 24: 18Sep 24: 18Sep 24Oct 24: 13Oct 24: 13Oct 24Nov 24: 7Nov 24: 7Nov 24Dec 24: 17Dec 24: 17Dec 24Jan 25: 26Jan 25: 2626Jan 25

The highlighted bar is January 2025. Hover a bar for its figure; the table below has every value.

FigureJanuary 2025December 2024ChangeSame month last yearChange
Tenders published6328+125%——
Estimated value€2,231,759€1,805,500+24%——
Buyers2015+33%——
Contracts awarded2617+53%——
Contract value (awarded)€399,596€1,120,867-64%——
Winners1612+33%——
Bids per contract1.01.2———
Single-bid contracts100%80%———

Buyers with the most tenders

Companies with the most contracts

Where the tenders were

  • Emilia-Romagna 8
  • Sicilia 6
  • Provincia Autonoma di Bolzano/Bozen 6
  • Piemonte 5
  • Marche 3

Procedures

  • Direct award 46
  • Negotiated procedure without prior publication 13
  • not stated 2
  • Negotiated procedure 1
  • Restricted procedure 1

Download the figures (CSV)

The report's aggregates: the figures, the comparisons and the top lists by name and count.

All reports: Nervous system drugs and analgesics

Questions and answers

How many nervous system drug tenders were published in Italy in January 2025?
63 (by 20 buyers); for comparison, December 2024: 28.
Who won the most nervous system drug tenders in Italy in January 2025?
By number of contracts: Aurobindo Pharma (Italia) S.R.L. in Forma Abbreviata Aurobindo S.R.L. (2), Alloga (Italia) S.R.L. (2), OTTOPHARMA S.R.L. (2), Ucb Pharma S.P.A. (1) and SANOFI S.R.L. (1); 16 companies won contracts in all.
Which buyers published the most nervous system drug tenders in January 2025?
Sanitaetsbetrieb der Autonomen Provinz Bozen (12), Azienda Sanitaria Provinciale (8), Azienda Sanitaria Locale TO3 (7), Azienda U.S.L. di Modena (6) and Azienda Sanitaria Territoriale di Ascoli Piceno (4).
How competitive were nervous system drug tenders in Italy in January 2025?
On average 1.0 bids per contract (5 contracts with a known number of bids); 100% of contracts had a single bid.
What were the contracts worth in January 2025?
€399,596 (awarded value, 26 contracts); median about €9,700.

How the report is made

Tenders published: the tenders of the sector or topic whose first notice is dated in the month (a tender counts in its sector and in up to three topics). Contracts awarded: the awards dated in the month, whenever their tender was published. Values in EUR, by value kind (never added together); medians are approximate (±3 %). Comparisons: with the reports of the previous month and of the same month a year earlier, each made the same way. The report was made on 27 October 2026 from the data of that day and is not changed afterwards; sources publish late, so later data for the month are not in it.